229 related articles for article (PubMed ID: 18728619)
1. Carcinoma-associated retinopathy-an electrophysiological and immunohistochemical correlation.
Link B; Schlötzer-Schrehardt U; Jünemann A
Retina; 2009 Jan; 29(1):69-72. PubMed ID: 18728619
[TBL] [Abstract][Full Text] [Related]
2. Waldenström's macroglobulinemia-associated retinopathy.
Sen HN; Chan CC; Caruso RC; Fariss RN; Nussenblatt RB; Buggage RR
Ophthalmology; 2004 Mar; 111(3):535-9. PubMed ID: 15019332
[TBL] [Abstract][Full Text] [Related]
3. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
Khan N; Huang JJ; Foster CS
Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
[TBL] [Abstract][Full Text] [Related]
5. Choroidal neovascularization associated with cancer-associated retinopathy.
Querques G; Thirkill CE; Hagege H; Soubrane G; Souied EH
Acta Ophthalmol; 2010 Aug; 88(5):571-5. PubMed ID: 19141145
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
[TBL] [Abstract][Full Text] [Related]
7. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.
Mantel I; Ramchand KV; Holder GE; Ohbayashi M; Morohoshi K; Patel N; Toda M; Fitzke FW; Bird AC; Ono SJ
Exp Mol Pathol; 2008 Apr; 84(2):90-101. PubMed ID: 18255057
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoma-associated retinopathy: a review with clinical examples].
Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
[TBL] [Abstract][Full Text] [Related]
9. A clinical triad to diagnose paraneoplastic retinopathy.
Jacobson DM; Thirkill CE; Tipping SJ
Ann Neurol; 1990 Aug; 28(2):162-7. PubMed ID: 2171418
[TBL] [Abstract][Full Text] [Related]
10. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
Murphy MA; Thirkill CE; Hart WM
J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma.
Harmon JP; Purvin VA; Guy J; Aptsiauri N; Sutton GP
Gynecol Oncol; 1999 Jun; 73(3):430-2. PubMed ID: 10366473
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to 46-kDa retinal antigen in a patient with breast carcinoma and cancer-associated retinopathy.
Ejma M; Misiuk-Hojło M; Gorczyca WA; Podemski R; Szymaniec S; Kuropatwa M; Rogozińska-Szczepka J; Bartnik W
Breast Cancer Res Treat; 2008 Jul; 110(2):269-71. PubMed ID: 17851760
[TBL] [Abstract][Full Text] [Related]
16. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
Dot C; Guigay J; Adamus G
Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
[TBL] [Abstract][Full Text] [Related]
17. Slowly progressive cancer-associated retinopathy.
Saito W; Kase S; Ohguro H; Furudate N; Ohno S
Arch Ophthalmol; 2007 Oct; 125(10):1431-3. PubMed ID: 17923561
[No Abstract] [Full Text] [Related]
18. Müller cell-specific autoantibodies in a patient with progressive loss of vision.
Peek R; Verbraak F; Coevoet HM; Kijlstra A
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1976-9. PubMed ID: 9727423
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma.
Eksandh L; Adamus G; Mosgrove L; Andréasson S
Arch Ophthalmol; 2008 Mar; 126(3):432-5. PubMed ID: 18332332
[No Abstract] [Full Text] [Related]
20. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
